Standard Biotools (LAB) Return on Invested Capital (2011 - 2025)

Standard Biotools (LAB) has 7 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2025.

• On a quarterly basis, Return on Invested Capital rose 5.0% year-over-year to 0.02% in Q1 2025; TTM through Mar 2025 was 0.02%, a 5.0% increase from a year earlier, with the FY2023 full-year figure at 0.22%, changed N/A from the prior year.
• Return on Invested Capital for Q1 2025 stood at 0.02%, up from 0.03% in the prior quarter.
• Over the last five years, Return on Invested Capital for LAB reached as high as 0.02% in Q1 2025 and fell as low as 0.53% in Q4 2022.
• Historically, Return on Invested Capital has averaged 0.11% across 4 years, with a median of 0.05% in 2023.
• Across the five-year window, Return on Invested Capital surged 48 bps in 2023 and grew 2 bps in 2024, its largest moves.
• Year by year, Return on Invested Capital stood at 0.53% in 2022, then soared by 91 bps to 0.05% in 2023, then surged by 46 bps to 0.03% in 2024, then advanced by 20 bps to 0.02% in 2025.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.02% in Q1 2025, 0.03% in Q4 2024, and 0.02% in Q3 2024.